Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Juncos

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Movement Disorders Clinical Practice|January 16, 2018
Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slowAasef G Shaikh, Stewart A Factor, Jorge Juncos
Journal of the Neurological Sciences|February 8, 2022
Pseudonystagmus in progressive supranuclear palsyHemani Ticku, Neel Fotedar, Jorge Juncos, et al.
CNS Spectrums|November 9, 2020
Diagnosing functional neurological disorder: seeing the whole pictureSarah C Lidstone, Walid Nassif, Jorge Juncos, et al.
JAMA|May 27, 2004
Measuring the effects of therapy in Parkinson diseaseClifford W Shults, Richard Haas, David Oakes, et al.
Neuropsychology|March 30, 2011
Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndromeEmily Graves Allen, Jessica E Hunter, Michele Rusin, et al.
Biological Psychiatry|October 26, 2005
Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders"Cathy Budman, Barbara Coffey, Leon Dure, et al.
Parkinsonism & Related Disorders|December 24, 2016
Understanding falls in progressive supranuclear palsyBrent Bluett, Irene Litvan, Shumin Cheng, et al.
Parkinsonism & Related Disorders|August 18, 2019
Hypertension and progressive supranuclear palsySoniya V Rabadia, Irene Litvan, Jorge Juncos, et al.
Parkinsonism & Related Disorders|January 9, 2018
Anti-inflammatory drug use and progressive supranuclear palsyConnie Marras, Christopher R Cunningham, Jiayi Hou, et al.
Schizophrenia Research|May 1, 2007
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophreniaMark S George, Christine E Molnar, Emily L Grenesko, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Movement Disorders Clinical Practice|January 16, 2018
Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slowAasef G Shaikh, Stewart A Factor, Jorge Juncos
Journal of the Neurological Sciences|February 8, 2022
Pseudonystagmus in progressive supranuclear palsyHemani Ticku, Neel Fotedar, Jorge Juncos, et al.
CNS Spectrums|November 9, 2020
Diagnosing functional neurological disorder: seeing the whole pictureSarah C Lidstone, Walid Nassif, Jorge Juncos, et al.
JAMA|May 27, 2004
Measuring the effects of therapy in Parkinson diseaseClifford W Shults, Richard Haas, David Oakes, et al.
Neuropsychology|March 30, 2011
Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndromeEmily Graves Allen, Jessica E Hunter, Michele Rusin, et al.
Biological Psychiatry|October 26, 2005
Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders"Cathy Budman, Barbara Coffey, Leon Dure, et al.
Parkinsonism & Related Disorders|December 24, 2016
Understanding falls in progressive supranuclear palsyBrent Bluett, Irene Litvan, Shumin Cheng, et al.
Parkinsonism & Related Disorders|August 18, 2019
Hypertension and progressive supranuclear palsySoniya V Rabadia, Irene Litvan, Jorge Juncos, et al.
Parkinsonism & Related Disorders|January 9, 2018
Anti-inflammatory drug use and progressive supranuclear palsyConnie Marras, Christopher R Cunningham, Jiayi Hou, et al.
Schizophrenia Research|May 1, 2007
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophreniaMark S George, Christine E Molnar, Emily L Grenesko, et al.
Pageof 2